CAS No 150812-12-7 RETIGABINE Pharmaceutical Intermediates
Overview
Raltigabine, also known as ezogabine, is a new anticonvulsant drug used primarily to treat epilepsy. It is a potassium channel opener that helps stabilize neuronal excitability and reduce the frequency of epileptic seizures. Raltigabine has been shown to be effective in treating partial-onset seizures in adults, making it a valuable addition to existing treatment options for epilepsy.
Its unique mechanism of action sets it apart from other anti-epileptic drugs, providing an alternative option for patients who may not respond to traditional therapies.
Physical and chemical properties
- Solubility: Soluble in organic solvents such as dimethyl sulfoxide (DMSO) and methanol, slightly soluble in water, and easy to prepare into various dosage forms.
- Stability: RETIGABINE exhibits good stability under recommended storage conditions, ensuring longer shelf life and reliability in therapeutic applications.
These properties make RETIGABINE suitable for the formulation of a variety of drug products, including tablets and oral solutions.
There are many advantages to using RETIGABINE in pharmaceutical preparations:
- Unique Mechanism of Action: Ratigabine's ability to open potassium channels provides a unique therapeutic approach, effectively stabilizing neuronal activity and reducing seizure frequency.
- Effectiveness in Patients with Refractory Epilepsy: Clinical studies have shown that RETIGABINE is effective in patients with refractory epilepsy, bringing hope to patients who have not been able to find relief with other medications.
- Regulatory Compliance: Our RETIGABINE is manufactured in accordance with international pharmaceutical standards, ensuring that it meets the strict requirements set by health authorities.
- Research and Development Support: We provide comprehensive technical support and documentation to assist researchers and pharmaceutical companies in the development process.
As a factory integrating production and trading, we are committed to providing customers with high-quality Raligabine. Our dedication to quality is reflected in our advanced manufacturing process and strict quality control measures.
- Expertise: Our dedicated team of professionals is dedicated to research and development, ensuring we are always at the forefront of pharmaceutical innovation.
- Customer-centric approach: We prioritize our customers' needs, providing customized solutions and responsive customer service to support their specific requirements.
- Sustainability: We are committed to using sustainable practices in our manufacturing process, ensuring minimal impact on the environment while maintaining product quality.
In conclusion, RETIGABINE is an important pharmaceutical ingredient that provides multiple benefits for the treatment of epilepsy. With our comprehensive production capabilities, high quality standards, and commitment to customer satisfaction, we are your ideal partner in the pharmaceutical industry. Choose our RETIGABINE for your formulation and experience the difference in quality and efficacy.
For inquiries or to place an order, please contact us today!